Treace Medical Concepts (TMCI) EPS (Weighted Average and Diluted) (2020 - 2025)
Historic EPS (Weighted Average and Diluted) for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to -$0.26.
- Treace Medical Concepts' EPS (Weighted Average and Diluted) fell 400.0% to -$0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.8, marking a year-over-year increase of 1919.19%. This contributed to the annual value of -$0.9 for FY2024, which is 1090.87% down from last year.
- Treace Medical Concepts' EPS (Weighted Average and Diluted) amounted to -$0.26 in Q3 2025, which was down 400.0% from -$0.28 recorded in Q2 2025.
- Treace Medical Concepts' 5-year EPS (Weighted Average and Diluted) high stood at -$0.01 for Q4 2024, and its period low was -$0.34 during Q2 2024.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.22 (2022), whereas its average is -$0.2.
- In the last 5 years, Treace Medical Concepts' EPS (Weighted Average and Diluted) crashed by 31063.05% in 2021 and then soared by 9049.01% in 2024.
- Over the past 5 years, Treace Medical Concepts' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.14 in 2021, then surged by 48.8% to -$0.07 in 2022, then crashed by 49.71% to -$0.1 in 2023, then soared by 90.49% to -$0.01 in 2024, then plummeted by 2508.91% to -$0.26 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.26 for Q3 2025, versus -$0.28 for Q2 2025 and -$0.25 for Q1 2025.